-

Shareholder Alert: Robbins LLP is Investigating OneSpan Inc. (OSPN) for Shareholders

SAN DIEGO & CHICAGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating OneSpan Inc. (NASDAQ: OSPN) to determine whether certain OneSpan officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. OneSpan and its subsidiaries design, develop, and market solutions for identity, security, and business productivity.

If you suffered a loss due to OneSpan Inc.'s misconduct, click here.

OneSpan Inc. (OSPN) Overstated its Revenue

OneSpan Inc. may have made false and misleading statements regarding the Company's internal policies and downplayed the likely negative impact on its profits. On August 4, 2020, OneSpan postponed its second quarter 2020 earnings release due to revenue recognition problems spanning from the first quarter of 2018 through the first quarter of 2020, "which caused overstatements of revenue." After market close on August 11, 2020, the Company announced that it would not be able to timely submit its SEC report for the quarter ending on June 30, 2020, that same quarter year-over-year revenues had declined, and withdrew its full year 2020 earnings guidance, which it had just confirmed one quarter earlier. On this news, the Company stock price fell almost 40% to close at $18.84 per share on August 12, 2020.

OneSpan Inc. (OSPN) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against OneSpan Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom